SlideShare a Scribd company logo
CASE PRESENTATION ON PULMONARY
TUBERCULOSIS
DONE BY:
ASHIMA JOSEPH
IV PHARM.D
CASE ABSTRACT:
A 50 Year old male was admitted in Karpagam hospital on 21/2/2020
His chief complaints were cough, poor appetite, excessive joint pain for 1
week, chest pain for 1 month, weight loss, evening rise in temperature, and
breathlessness.
On physical examination he was found to be afebrile, conscious and
oriented. On laboratory examination his hemoglobin, total count, lymphocytes,
MCH, MCV, MCHC and RBC levels was found to be decreased. He had a past
medical history of tuberculosis and he discontinued the medications. Finally on
laboratory and specific investigation the patient was diagnosed as
PULMONARY TUBERCULOSIS.
• He was treated with following medication
ATT-CAT- II (8MONTHS)
T.Dolo
PATIENT DETAILS
NAME Mrs. X
AGE 50 YEARS
SEX MALE
IP.NO K18061268
DATE OF ADMISSION 21/2/20
SUBJECTIVE
Reasons for admission
Cough
poor appetite
excessive joint pain for 1 week
chest pain for 1 month
weight loss
evening rise in temperature
breathlessness
Social History:
Smoker -yes
Alcoholic-yes
Marital status-Married
Allergies-Nil
Past medical history- TUBERCULOSIS
Past medication history-ATT CAT-I DISCONTINUED
OBJECTIVE
VITALS:
COMPONENTS OBSERVATION NORMAL VALUES
BLOOD PRESSURE 120/80 mm Hg 120/80 mm Hg
RESPIRATORY RATE 16 breaths/min 12-20 breaths/min
PULSE 100 beats/min 60-100 beats/min
TEMPARATURE 98.4 °F 98.4 °F
On Examination:
Afebrile
Conscious
Oriented
LABORATORY INVESTIGATIONS:
COMPONENTS FINDINGS NORMAL VALUES
HAEMOGLOBIN 7.1 gm/dl 14-18 gm/dl
TOTAL COUNT 11,800 cells/cu.mm 4,000-11,000 cells/cu.mm
PLATELETS 4,30,000 1.5 to 4.5 lakh/cumm
MONOCYTES 1.8% 2-10%
TOTAL RBC 3.39
millions/cumm
4.7-6.1 millions/cumm
MCH 21.1 Pg/cell 27-33 Pg/cell
MCHC 28.3 gm/dl 33-36 gm/dl
LYMPHOCYTES 14.6% 20-40%
MCV 74 fl 80-96 fl
RBS 118.4 mg/dl 70-140 mg/dl
SPECIFIC TEST:
• Sputum culture and sensitivity test (+ve).
• Chest X-ray.
ASSESSMENT
CAUSES:
Tuberculosis is caused by bacteria (Mycobacterium tuberculosis) that spread from person to
person through microscopic droplets released into the air.
This can happen when someone with the untreated active form of tuberculosis coughs, speaks,
sneezes, spits, laughs or sings.
RISK FACTORS:
Low body weight
Babies and young children, whose immune systems have not matured
People with chronic conditions such as diabetes or kidney disease
People with HIV/AIDS
Organ transplant recipients
Cancer patients undergoing chemotherapy
People receiving certain specialized treatments for autoimmune disorders
DIAGNOSIS
PULMONARY TUBERCULOSIS
PLAN
BRAND NAME GENERIC NAME GIVEN
ROUTE
GIVEN DOSE FREQUENCY
ATT-CAT- II
(8MONTHS)
Isoniazid(H)
Rifampicin(R)
Pyrazinamide(Z)
Ethambutol(E)
Streptomycin(S)
Oral
Oral
Oral
Oral
IM
2 Months –
R150,H75,E275,Z400,S750
1 month-R150,H75,E275,Z400
5 Months- R150, H75,E275
TID
T.Dolo Paracetamol Oral 650mg SOS
DRUG CHART
DRUG PROFILE
DRUG CLASS MOA ADR
ATT-CAT- II
Isoniazid(H)
Rifampicin(R)
Pyrazinamide(Z)
Ethambutol(E)
Streptomycin(S)
Antituberculosis
drug
inhibition of mycolic acid synthesis
inhibits bacterial RNA synthesis by binding strongly to
the beta subunit of DNA-dependent RNA polymerase,
preventing attachment of the enzyme to DNA, and thus
blocking initiation of RNA transcription
inhibition of mycolic acid synthesis
inhibits the synthesis of metabolites, subsequently
impairing cell metabolism and cell multiplication
eventually leading to cell death
inhibit normal bacterial protein synthesis
Peripheral neuritis,
hepatotoxicity, anemia, GI
disturbances
Hepatotoxicity, fever,
chills, joint pain,GI
disturbances
Hepatotoxicity,
hyperuricemia, GI
disturbances skin rashes
Optic neuritis,
hyperuricemia, GI
disturbances, skin rashes
Ototoxicity,
nephrotoxicity,
neuromuscular blockade
Paracetamol Antipyretic and
analgesic
Inhibit release of prostaglandins in the CNS and by
inhibit endogenous pyrogens at the hypothalamic
thermoregulator center
Nephrotoxicity,
hepatotoxicity, skin rashes
and GI disturbances
PHARMACIST INTERVENTION
DRUG-DRUG INTERACTION
ISONIAZID -- ACETAMINOPHEN
Concurrent use of ACETAMINOPHEN and ISONIAZID may result in an increased risk of hepatotoxicity.
Mechanism-inhibition of CYP2E1-mediated metabolism of acetaminophen by isoniazid.
Acetaminophen use should be avoided or limited in patients taking isoniazid.
ISONIAZID-RIFAMPIN
Concurrent use of RIFAMPIN and ISONIAZID may result in hepatotoxicity.
Mechanism- increased isoniazid metabolism
For patients on concurrent isoniazid and rifampin, monitor liver function tests
PYRAZINAMIDE-RIFAMPIN
Concurrent use of PYRAZINAMIDE and RIFAMPIN may result in severe hepatic injury.
Patients should be monitored throughout the entire course of therapy since a majority of patients have onset of
symptoms of liver injury after the fourth week of therapy.
DRUG-FOOD INTERACTION
ACETAMINOPHEN-CABBAGE
Concurrent use of ACETAMINOPHEN and CABBAGE may result in decreased acetaminophen
effectiveness.
Cabbage may enhance the glucuronidation of acetaminophen to inactive metabolites.
RIFAMPIN-FOOD
Concurrent use of RIFAMPIN and FOOD may result in decreased rifampin concentrations.
Rifampin should be administered one hour before or two hours after a meal with a full glass of water.
ISONIAZID-FOOD
Concurrent use of ISONIAZID and FOOD may result in decreased isoniazid exposure.
Isoniazid should be administered on an empty stomach.
PATIENT COUNSELLING
• Educate the patient about the disease severity, the importance of adherence to therapy
and the complications of tuberculosis.
• Patient are advice to use tissues to cover when they cough and sneezes
• Tissues should be disposed appropriately and not left on outer space
• A surgical mask must worn by the patient whenever they leave the isolation room.
• Take medications properly.
PATIENT COUNSLLING-BASED ON DRUG
PROFILE
• Isoniazid should be administered on an empty stomach
• Rifampin should be administered one hour before or two hours after a meal with a
full glass of water.
• Rifampin stains body fluids such as urine, saliva, sweat, sputum, etc. orange red
which is harmless.
THANK YOU

More Related Content

What's hot

Case presentation on Alcoholic liver disease
Case presentation on Alcoholic liver diseaseCase presentation on Alcoholic liver disease
Case presentation on Alcoholic liver disease
HAMMADKC
 
CASE PRESENTATION ON JAUNDICE
CASE PRESENTATION ON JAUNDICECASE PRESENTATION ON JAUNDICE
CASE PRESENTATION ON JAUNDICE
Rahman Khan
 
Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)
HAMMADKC
 
A case study on anemia with congestive heart failure
A case study on anemia with congestive heart failureA case study on anemia with congestive heart failure
A case study on anemia with congestive heart failure
martinshaji
 
Tuberculosis cases
Tuberculosis casesTuberculosis cases
Tuberculosis cases
Sameh Abdel-ghany
 
Meningitis case presentation
Meningitis  case presentationMeningitis  case presentation
Meningitis case presentation
Dr.B. Roshitha
 
case study of jaundice
case study  of jaundice case study  of jaundice
case study of jaundice
shifanishifani
 
A Case Presentation on Peptic ulcer
A Case Presentation on Peptic ulcerA Case Presentation on Peptic ulcer
A Case Presentation on Peptic ulcer
DR. METI.BHARATH KUMAR
 
a case study on urinary tract infection ( UTI)
a case study on urinary tract infection ( UTI) a case study on urinary tract infection ( UTI)
a case study on urinary tract infection ( UTI)
martinshaji
 
case ppt on UTI with IBD
case ppt on UTI with IBDcase ppt on UTI with IBD
case ppt on UTI with IBD
Dr B Naga Raju
 
A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertension
DrMaheshGurajapu
 
A case study on uti
A case study on utiA case study on uti
A case study on uti
DrMaheshGurajapu
 
Case presentation on STROKE
Case presentation on STROKECase presentation on STROKE
Case presentation on STROKE
Shiva Kumar
 
A Case Presentation on Angina pectoris
A Case Presentation on Angina pectoris A Case Presentation on Angina pectoris
A Case Presentation on Angina pectoris
DR. METI.BHARATH KUMAR
 
Case Presentation on Epilepsy
Case Presentation on EpilepsyCase Presentation on Epilepsy
Case Presentation on Epilepsy
DR. METI.BHARATH KUMAR
 
Myocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
Satya satyanittu4
 
8. a case study on typhoid fever
8. a case study on typhoid fever8. a case study on typhoid fever
8. a case study on typhoid fever
Dr. Ajita Sadhukhan
 
CASE PRESENTATION ON ACUTE PANCREATITIS
CASE PRESENTATION ON ACUTE PANCREATITISCASE PRESENTATION ON ACUTE PANCREATITIS
CASE PRESENTATION ON ACUTE PANCREATITIS
DR. METI.BHARATH KUMAR
 
Migraine case Presentation SOAP format for PharmD students
Migraine case Presentation SOAP format for PharmD studentsMigraine case Presentation SOAP format for PharmD students
Migraine case Presentation SOAP format for PharmD students
Abel C. Mathew
 
case presentation on CKD
case presentation on CKDcase presentation on CKD
case presentation on CKD
PERCY ARPITHA JENNIFER
 

What's hot (20)

Case presentation on Alcoholic liver disease
Case presentation on Alcoholic liver diseaseCase presentation on Alcoholic liver disease
Case presentation on Alcoholic liver disease
 
CASE PRESENTATION ON JAUNDICE
CASE PRESENTATION ON JAUNDICECASE PRESENTATION ON JAUNDICE
CASE PRESENTATION ON JAUNDICE
 
Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)
 
A case study on anemia with congestive heart failure
A case study on anemia with congestive heart failureA case study on anemia with congestive heart failure
A case study on anemia with congestive heart failure
 
Tuberculosis cases
Tuberculosis casesTuberculosis cases
Tuberculosis cases
 
Meningitis case presentation
Meningitis  case presentationMeningitis  case presentation
Meningitis case presentation
 
case study of jaundice
case study  of jaundice case study  of jaundice
case study of jaundice
 
A Case Presentation on Peptic ulcer
A Case Presentation on Peptic ulcerA Case Presentation on Peptic ulcer
A Case Presentation on Peptic ulcer
 
a case study on urinary tract infection ( UTI)
a case study on urinary tract infection ( UTI) a case study on urinary tract infection ( UTI)
a case study on urinary tract infection ( UTI)
 
case ppt on UTI with IBD
case ppt on UTI with IBDcase ppt on UTI with IBD
case ppt on UTI with IBD
 
A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertension
 
A case study on uti
A case study on utiA case study on uti
A case study on uti
 
Case presentation on STROKE
Case presentation on STROKECase presentation on STROKE
Case presentation on STROKE
 
A Case Presentation on Angina pectoris
A Case Presentation on Angina pectoris A Case Presentation on Angina pectoris
A Case Presentation on Angina pectoris
 
Case Presentation on Epilepsy
Case Presentation on EpilepsyCase Presentation on Epilepsy
Case Presentation on Epilepsy
 
Myocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
 
8. a case study on typhoid fever
8. a case study on typhoid fever8. a case study on typhoid fever
8. a case study on typhoid fever
 
CASE PRESENTATION ON ACUTE PANCREATITIS
CASE PRESENTATION ON ACUTE PANCREATITISCASE PRESENTATION ON ACUTE PANCREATITIS
CASE PRESENTATION ON ACUTE PANCREATITIS
 
Migraine case Presentation SOAP format for PharmD students
Migraine case Presentation SOAP format for PharmD studentsMigraine case Presentation SOAP format for PharmD students
Migraine case Presentation SOAP format for PharmD students
 
case presentation on CKD
case presentation on CKDcase presentation on CKD
case presentation on CKD
 

Similar to CASE PRESENTATION ON TUBERCULOSIS

Soap format
Soap formatSoap format
Soap format
Pooja Panjwani
 
Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia
NITISH SHAH
 
Disseminated tuberculosis ppt1
Disseminated tuberculosis ppt1Disseminated tuberculosis ppt1
Disseminated tuberculosis ppt1
BhuvanaDarawadi
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
jagdhani_r
 
Case Presentation MAI
Case Presentation MAICase Presentation MAI
Case Presentation MAIJoseph Helms
 
Guidelines for antibiotic use in icu
Guidelines for  antibiotic use in icuGuidelines for  antibiotic use in icu
Guidelines for antibiotic use in icu
Mahmod Almahjob
 
Pneumonia
PneumoniaPneumonia
Module 7 antimicrobials v2
Module 7 antimicrobials v2Module 7 antimicrobials v2
Module 7 antimicrobials v2
OlgaPaterson1
 
Case study on peptic ulcer disease
Case study on peptic ulcer diseaseCase study on peptic ulcer disease
Case study on peptic ulcer disease
krishna mathiyarasan
 
ATT.pptx
 ATT.pptx ATT.pptx
Diffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung DiseasesDiffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung Diseases
Ashraf ElAdawy
 
Anti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case StudyAnti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case Study
velspharmd
 
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case ReportCOVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
semualkaira
 
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case reportCOVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
komalicarol
 
Case Presentation in SOAP Format
Case Presentation in SOAP FormatCase Presentation in SOAP Format
Case Presentation in SOAP Format
Abel C. Mathew
 
Pneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and curePneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and cure
azadabubaker
 
MALARIA CASE MANAGEMENT.pdf
MALARIA CASE MANAGEMENT.pdfMALARIA CASE MANAGEMENT.pdf
MALARIA CASE MANAGEMENT.pdf
TrevorTakundaDzvuke
 
addison disease
 addison disease  addison disease
addison disease
Alanoud moh
 
Antifungal therapy in sepsis
Antifungal therapy in sepsisAntifungal therapy in sepsis
Antifungal therapy in sepsis
Adel Hammodi
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
anitha challa
 

Similar to CASE PRESENTATION ON TUBERCULOSIS (20)

Soap format
Soap formatSoap format
Soap format
 
Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia Pediatric community Acquired Pneumonia
Pediatric community Acquired Pneumonia
 
Disseminated tuberculosis ppt1
Disseminated tuberculosis ppt1Disseminated tuberculosis ppt1
Disseminated tuberculosis ppt1
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Case Presentation MAI
Case Presentation MAICase Presentation MAI
Case Presentation MAI
 
Guidelines for antibiotic use in icu
Guidelines for  antibiotic use in icuGuidelines for  antibiotic use in icu
Guidelines for antibiotic use in icu
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Module 7 antimicrobials v2
Module 7 antimicrobials v2Module 7 antimicrobials v2
Module 7 antimicrobials v2
 
Case study on peptic ulcer disease
Case study on peptic ulcer diseaseCase study on peptic ulcer disease
Case study on peptic ulcer disease
 
ATT.pptx
 ATT.pptx ATT.pptx
ATT.pptx
 
Diffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung DiseasesDiffuse Parenchymal Lung Diseases
Diffuse Parenchymal Lung Diseases
 
Anti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case StudyAnti tuberculosis drug - induced hepatitis – A Case Study
Anti tuberculosis drug - induced hepatitis – A Case Study
 
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case ReportCOVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
COVID-19 Pneumonia in a Congenital Adrenal Hyperplasia; A Case Report
 
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case reportCOVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
COVID-19 pneumonia in a congenital adrenal hyperplasia; a case report
 
Case Presentation in SOAP Format
Case Presentation in SOAP FormatCase Presentation in SOAP Format
Case Presentation in SOAP Format
 
Pneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and curePneumonia, definition, symptoms, causes and cure
Pneumonia, definition, symptoms, causes and cure
 
MALARIA CASE MANAGEMENT.pdf
MALARIA CASE MANAGEMENT.pdfMALARIA CASE MANAGEMENT.pdf
MALARIA CASE MANAGEMENT.pdf
 
addison disease
 addison disease  addison disease
addison disease
 
Antifungal therapy in sepsis
Antifungal therapy in sepsisAntifungal therapy in sepsis
Antifungal therapy in sepsis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 

Recently uploaded

Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 

Recently uploaded (20)

Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 

CASE PRESENTATION ON TUBERCULOSIS

  • 1. CASE PRESENTATION ON PULMONARY TUBERCULOSIS DONE BY: ASHIMA JOSEPH IV PHARM.D
  • 2. CASE ABSTRACT: A 50 Year old male was admitted in Karpagam hospital on 21/2/2020 His chief complaints were cough, poor appetite, excessive joint pain for 1 week, chest pain for 1 month, weight loss, evening rise in temperature, and breathlessness. On physical examination he was found to be afebrile, conscious and oriented. On laboratory examination his hemoglobin, total count, lymphocytes, MCH, MCV, MCHC and RBC levels was found to be decreased. He had a past medical history of tuberculosis and he discontinued the medications. Finally on laboratory and specific investigation the patient was diagnosed as PULMONARY TUBERCULOSIS.
  • 3. • He was treated with following medication ATT-CAT- II (8MONTHS) T.Dolo
  • 4. PATIENT DETAILS NAME Mrs. X AGE 50 YEARS SEX MALE IP.NO K18061268 DATE OF ADMISSION 21/2/20
  • 6. Reasons for admission Cough poor appetite excessive joint pain for 1 week chest pain for 1 month weight loss evening rise in temperature breathlessness
  • 7. Social History: Smoker -yes Alcoholic-yes Marital status-Married Allergies-Nil Past medical history- TUBERCULOSIS Past medication history-ATT CAT-I DISCONTINUED
  • 9. VITALS: COMPONENTS OBSERVATION NORMAL VALUES BLOOD PRESSURE 120/80 mm Hg 120/80 mm Hg RESPIRATORY RATE 16 breaths/min 12-20 breaths/min PULSE 100 beats/min 60-100 beats/min TEMPARATURE 98.4 °F 98.4 °F
  • 11. LABORATORY INVESTIGATIONS: COMPONENTS FINDINGS NORMAL VALUES HAEMOGLOBIN 7.1 gm/dl 14-18 gm/dl TOTAL COUNT 11,800 cells/cu.mm 4,000-11,000 cells/cu.mm PLATELETS 4,30,000 1.5 to 4.5 lakh/cumm MONOCYTES 1.8% 2-10% TOTAL RBC 3.39 millions/cumm 4.7-6.1 millions/cumm MCH 21.1 Pg/cell 27-33 Pg/cell MCHC 28.3 gm/dl 33-36 gm/dl LYMPHOCYTES 14.6% 20-40% MCV 74 fl 80-96 fl RBS 118.4 mg/dl 70-140 mg/dl
  • 12. SPECIFIC TEST: • Sputum culture and sensitivity test (+ve). • Chest X-ray.
  • 14. CAUSES: Tuberculosis is caused by bacteria (Mycobacterium tuberculosis) that spread from person to person through microscopic droplets released into the air. This can happen when someone with the untreated active form of tuberculosis coughs, speaks, sneezes, spits, laughs or sings. RISK FACTORS: Low body weight Babies and young children, whose immune systems have not matured People with chronic conditions such as diabetes or kidney disease People with HIV/AIDS Organ transplant recipients Cancer patients undergoing chemotherapy People receiving certain specialized treatments for autoimmune disorders
  • 16. PLAN
  • 17. BRAND NAME GENERIC NAME GIVEN ROUTE GIVEN DOSE FREQUENCY ATT-CAT- II (8MONTHS) Isoniazid(H) Rifampicin(R) Pyrazinamide(Z) Ethambutol(E) Streptomycin(S) Oral Oral Oral Oral IM 2 Months – R150,H75,E275,Z400,S750 1 month-R150,H75,E275,Z400 5 Months- R150, H75,E275 TID T.Dolo Paracetamol Oral 650mg SOS DRUG CHART
  • 18. DRUG PROFILE DRUG CLASS MOA ADR ATT-CAT- II Isoniazid(H) Rifampicin(R) Pyrazinamide(Z) Ethambutol(E) Streptomycin(S) Antituberculosis drug inhibition of mycolic acid synthesis inhibits bacterial RNA synthesis by binding strongly to the beta subunit of DNA-dependent RNA polymerase, preventing attachment of the enzyme to DNA, and thus blocking initiation of RNA transcription inhibition of mycolic acid synthesis inhibits the synthesis of metabolites, subsequently impairing cell metabolism and cell multiplication eventually leading to cell death inhibit normal bacterial protein synthesis Peripheral neuritis, hepatotoxicity, anemia, GI disturbances Hepatotoxicity, fever, chills, joint pain,GI disturbances Hepatotoxicity, hyperuricemia, GI disturbances skin rashes Optic neuritis, hyperuricemia, GI disturbances, skin rashes Ototoxicity, nephrotoxicity, neuromuscular blockade Paracetamol Antipyretic and analgesic Inhibit release of prostaglandins in the CNS and by inhibit endogenous pyrogens at the hypothalamic thermoregulator center Nephrotoxicity, hepatotoxicity, skin rashes and GI disturbances
  • 20. DRUG-DRUG INTERACTION ISONIAZID -- ACETAMINOPHEN Concurrent use of ACETAMINOPHEN and ISONIAZID may result in an increased risk of hepatotoxicity. Mechanism-inhibition of CYP2E1-mediated metabolism of acetaminophen by isoniazid. Acetaminophen use should be avoided or limited in patients taking isoniazid. ISONIAZID-RIFAMPIN Concurrent use of RIFAMPIN and ISONIAZID may result in hepatotoxicity. Mechanism- increased isoniazid metabolism For patients on concurrent isoniazid and rifampin, monitor liver function tests PYRAZINAMIDE-RIFAMPIN Concurrent use of PYRAZINAMIDE and RIFAMPIN may result in severe hepatic injury. Patients should be monitored throughout the entire course of therapy since a majority of patients have onset of symptoms of liver injury after the fourth week of therapy.
  • 21. DRUG-FOOD INTERACTION ACETAMINOPHEN-CABBAGE Concurrent use of ACETAMINOPHEN and CABBAGE may result in decreased acetaminophen effectiveness. Cabbage may enhance the glucuronidation of acetaminophen to inactive metabolites. RIFAMPIN-FOOD Concurrent use of RIFAMPIN and FOOD may result in decreased rifampin concentrations. Rifampin should be administered one hour before or two hours after a meal with a full glass of water. ISONIAZID-FOOD Concurrent use of ISONIAZID and FOOD may result in decreased isoniazid exposure. Isoniazid should be administered on an empty stomach.
  • 22. PATIENT COUNSELLING • Educate the patient about the disease severity, the importance of adherence to therapy and the complications of tuberculosis. • Patient are advice to use tissues to cover when they cough and sneezes • Tissues should be disposed appropriately and not left on outer space • A surgical mask must worn by the patient whenever they leave the isolation room. • Take medications properly.
  • 23. PATIENT COUNSLLING-BASED ON DRUG PROFILE • Isoniazid should be administered on an empty stomach • Rifampin should be administered one hour before or two hours after a meal with a full glass of water. • Rifampin stains body fluids such as urine, saliva, sweat, sputum, etc. orange red which is harmless.